Conceptus Appoints D. Keith Grossman President and Chief Executive Officer

Conceptus, Inc. (Nasdaq: CPTS) announced today that D. Keith Grossman, 51, has been appointed President and Chief Executive Officer, effective immediately. Mr. Grossman succeeds Mark M. Sieczkarek, 57, who has resigned as the Company's President, Chief Executive Officer and as a member of the Board of Directors. Mr. Grossman has also been appointed to the Company's Board of Directors.

Mr. Grossman previously served as a Managing Director at TPG, one of the world's largest private equity firms, where he initiated and led the medical device venture investing effort, and also served as a Senior Advisor to the firm's buyout fund. During his time at TPG, Mr. Grossman led or participated in a broad range of investments, from early stage companies to large acquisitions.

Prior to joining TPG in 2007, Mr. Grossman spent 23 years in a variety of relevant industry operating roles, including as President and CEO of Thoratec Corporation from 1996 to 2006. While Mr. Grossman was CEO of Thoratec, the company pioneered a new market and category of implantable therapeutic devices for heart failure patients, which led to an increase in revenues from approximately $3 million to over $200 million, while expanding Thoratec's market value more than twelve-fold to approximately $1.2 billion. Since 2006, Mr. Grossman has remained an active member of Thoratec's Board of Directors, during which time the company has continued its growth and market leadership.